Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and ATP levels in cells

Details for Australian Patent Application No. 2005307885 (hide)

International Classifications

Event Publications

14 June 2007 PCT application entered the National Phase

PCT publication WO2006/055597 Priority application(s): WO2006/055597

28 June 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 May 2007

11 November 2010 Assignment before Grant

Bioceuticals, Inc. The application has been assigned to Max International, LLC

23 December 2010 Application Accepted

Published as AU-B-2005307885

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.